CGNXCognex Corporation

$55.56+21% 1Y

Is the price fair?

Watch

A demanding price: priced for +13% a year vs +7% a year delivered and rich vs its sector.

2 to watch, 1 neutral
What the price assumes~+13% a year

Priced for ~13% a year FCF growth. The price demands more than its three-year revenue growth of 7% a year, priced for acceleration.

Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 53.4 vs a 45.9 median over 41 quarters (+16% vs median).

Vs sector (EV/EBIT)37.8×

Sector median 29.4× across 209 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Unless marked, from derived, as of Jul 5, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)behind 89% of the market
FCF yieldbehind 77% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What CGNX's price assumes

Cognex Corporation trades at 53.4× earnings against 35.5× for the median Scientific & Technical Instruments name, more expensive than its own group.

53.4

Trailing P/E · Scientific & Technical Instruments median 35.5 · 1.51× the median: the market pays up for this one

Price / sales
8.58

Price / sales · today's price, trailing year to Jul 5, 2026

Free cash flow yield
2.9%

Free cash flow yield · Scientific & Technical Instruments median 3.9%

Growth the price implies
+13%

Growth the price implies · The price pays for +13% free cash flow growth a year for a decade; the business has delivered +12% a year over the last three.

Details›
Price / booktoday's price, trailing year to Jul 5, 2026
5.74
EV / EBITtoday's price, trailing year to Jul 5, 2026
37.8
EV / salestoday's price, trailing year to Jul 5, 2026
8.27
Technology median P/E450 names
34.1
Scientific & Technical Instruments median P/E17 names
35.5
Free cash flow, trailing twelve months
$268M
Market capitalisation168.2 million shares, counted Aug 2, 2026
$9.35B
3-year revenue growth
+6.9%
3-year free cash flow growth
+12%
What the market has paid for these earnings: 41 quarters of its own multiple × $1.04 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$40.02
Its own P/E history, median$47.73
Its own P/E history, upper quartile$59.45
52-week range$34.70 – $72.45
Today$55.56

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

What is it worth?

Today's price against what its own multiples, its cash flow and your growth assumption say it is worth.

Against its own past

Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.